Dai W, Pan H Q, Ouyang B, Greenberg J M, Means R T, Li B, Cardie J
Department of Internal Medicine, University of Cincinnati College of Medicine, OH 45267-0508, USA.
Leukemia. 1996 Jun;10(6):978-83.
tif is a recently cloned and characterized cDNA predicting a transmembrane protein with a putative tyrosine kinase structure in its cytoplasmic domain. By analysis of the purified tif cytoplasmic domain expressed in Escherichia coli, we have demonstrated that tif is an active protein tyrosine kinase capable of autophosphorylation on tyrosine residues and this phosphorylation is inhibited by a tyrosine-specific inhibitor genistein. Northern blot analyses of various leukemia cell lines have revealed that tif mRNA expression is primarily confined to those bearing erythroid and megakaryocytic phenotypes. Megakaryocytic differentiation of K562 and HEL cells induced by phorbol 12-myristate 13-acetate is accompanied by down-regulation of tif mRNA expression. In addition, treatment of K562 and HEL with hexamethylene bis-acetamide, but not with hemin, decreases the steady-state level of tif mRNA. These combined results suggest that the receptor tyrosine kinase tif is involved in hematopoietic development.
tif是最近克隆并鉴定的一个cDNA,它预测的跨膜蛋白在其胞质结构域具有推定的酪氨酸激酶结构。通过对在大肠杆菌中表达的纯化tif胞质结构域进行分析,我们已证明tif是一种活性蛋白酪氨酸激酶,能够在酪氨酸残基上进行自身磷酸化,且这种磷酸化被酪氨酸特异性抑制剂染料木黄酮所抑制。对各种白血病细胞系的Northern印迹分析表明,tif mRNA的表达主要局限于那些具有红系和巨核细胞表型的细胞系。佛波酯12 -肉豆蔻酸酯13 -乙酸酯诱导的K562和HEL细胞的巨核细胞分化伴随着tif mRNA表达的下调。此外,用六亚甲基双乙酰胺处理K562和HEL细胞,而不是用血红素处理,会降低tif mRNA的稳态水平。这些综合结果表明,受体酪氨酸激酶tif参与造血发育。